Catalyst Pharmaceuticals Inc Earnings

Catalyst Pharmaceuticals Inc’s revenue jumped 28.26% since last year same period to $141.82Mn in the Q4 2024. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 10.2% jump in its revenue since last 3-months.

Catalyst Pharmaceuticals Inc’s net profit jumped 60.53% since last year same period to $55.94Mn in the Q4 2024. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 27.46% jump in its net profits since last 3-months.

Catalyst Pharmaceuticals Inc’s net profit margin jumped 25.16% since last year same period to 39.44% in the Q4 2024. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 15.67% jump in its net profit margins since last 3-months.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.32 - a 6.67% jump from last quarter’s estimates.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.32.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) jumped 125.81% since last year same period to 0.7 in the Q4 2024. This indicates that the Catalyst Pharmaceuticals Inc has generated 125.81% annual rate of jump in its earning per share (EPS) in the last 4 quarters.